ResearcherShanghai Jiao Tong UniversityActive in the last 2 years

Yiling Meng

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5075448668. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2023: 1 paper · 2024: 1 paper

Papers 2

ISG15 Promotes Progression and Gemcitabine Resistance of Pancreatic Cancer Cells Through ATG7. Co-author DOI 10.7150/ijbs.85424 ↗
Metformin inhibits the growth of pancreatic cancer cells by inducing degradation of mutant p53 protein Co-author DOI 10.21203/rs.3.rs-3174433/v1 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Pingting Zhou · 1 shared paper, 2024 · strength 0.21
- Paper ISG15 Promotes Progression and Gemcitabine Resistance of Pancreatic Cancer Cells Through ATG7. DOI 10.7150/ijbs.85424 ↗
Dong Li · 1 shared paper, 2024 · strength 0.21
- Paper ISG15 Promotes Progression and Gemcitabine Resistance of Pancreatic Cancer Cells Through ATG7. DOI 10.7150/ijbs.85424 ↗
Guangbo Wu · 1 shared paper, 2023 · strength 0.18
- Paper Metformin inhibits the growth of pancreatic cancer cells by inducing degradation of mutant p53 protein DOI 10.21203/rs.3.rs-3174433/v1 ↗
Meng Luo · 1 shared paper, 2023 · strength 0.18
- Paper Metformin inhibits the growth of pancreatic cancer cells by inducing degradation of mutant p53 protein DOI 10.21203/rs.3.rs-3174433/v1 ↗
Dong Li · 1 shared paper, 2023 · strength 0.18
- Paper Metformin inhibits the growth of pancreatic cancer cells by inducing degradation of mutant p53 protein DOI 10.21203/rs.3.rs-3174433/v1 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.